237 related articles for article (PubMed ID: 18442814)
1. Genetics of humoral and cytokine activation in heart failure and its importance for risk stratification of patients.
Spinarová L; Spinar J; Vasků A; Pávková-Goldbergová M; Ludka O; Tomandl J; Vítovec J
Exp Mol Pathol; 2008 Jun; 84(3):251-5. PubMed ID: 18442814
[TBL] [Abstract][Full Text] [Related]
2. [Does G8002A polymorphism in endothelin gene have a meaning for other risks at the patients with heart failure?].
Spinarová L; Spinar J; Vasků A; Ludka O; Vitovec J; Goldbergová M; Hude P; Krejcí J; Pavelcíková H
Vnitr Lek; 2006 Jan; 52(1):34-9. PubMed ID: 16526196
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory cytokine gene variants in coronary artery disease patients in Greece.
Manginas A; Tsiavou A; Chaidaroglou A; Giamouzis G; Degiannis D; Panagiotakos D; Cokkinos DV
Coron Artery Dis; 2008 Dec; 19(8):575-82. PubMed ID: 19005292
[TBL] [Abstract][Full Text] [Related]
4. TNFalpha in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device.
Bruggink AH; van Oosterhout MF; De Jonge N; Gmelig-Meyling FH; De Weger RA
Transpl Immunol; 2008 Apr; 19(1):64-8. PubMed ID: 18346639
[TBL] [Abstract][Full Text] [Related]
5. Big endothelin in chronic heart failure: marker of disease severity or genetic determination?
Spinarová L; Spinar J; Vasků A; Goldbergová M; Ludka O; Toman J; Vítovec J; Tomandlová M; Tomandl J
Int J Cardiol; 2004 Jan; 93(1):63-8. PubMed ID: 14729437
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of tumor necrosis factor-alpha correlate with the six-minute walk test results in patients with mild to moderate heart failure.
Boffa GM; Zaninotto M; Nalli C; Forni M; Tiso E; Razzolini R; Plebani M
Ital Heart J; 2004 Jan; 5(1):48-52. PubMed ID: 15080581
[TBL] [Abstract][Full Text] [Related]
7. Adrenomedullin and endothelin-1 are related to inflammation in chronic heart failure.
Gombos T; Förhécz Z; Pozsonyi Z; Wallentin S; Papassotiriou J; Kunde J; Morgenthaler NG; Jánoskuti L; Prohászka Z
Inflamm Res; 2009 Jun; 58(6):298-305. PubMed ID: 19212702
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients.
Collins RP; Palmer BR; Pilbrow AP; Frampton CM; Troughton RW; Yandle TG; Skelton L; Richards AM; Cameron VA
Am Heart J; 2006 Aug; 152(2):312-20. PubMed ID: 16875916
[TBL] [Abstract][Full Text] [Related]
9. The angiotensin-converting enzyme insertion/deletion and the endothelin -134 3A/4A gene polymorphisms in patients with chronic plaque psoriasis.
Weger W; Hofer A; Wolf P; El-Shabrawi Y; Renner W; Kerl H; Salmhofer W
Exp Dermatol; 2007 Dec; 16(12):993-8. PubMed ID: 18031458
[TBL] [Abstract][Full Text] [Related]
10. Positive association between two polymorphic sites (+134 insA/delA and G198T) of the endothelin-1 gene and chronic obstructive pulmonary disease. A case-control study.
Sampsonas F; Antonacopoulou A; Spathas D; Lykouras D; Kalofonos H; Flordellis C; Spiropoulos K; Siafakas N
Respir Med; 2010 Jan; 104(1):114-20. PubMed ID: 19640695
[TBL] [Abstract][Full Text] [Related]
11. Gene polymorphisms of TNF-alpha-308 (G/A), IL-10(-1082) (G/A), IL-6(-174) (G/C) and IL-1Ra (VNTR) in Egyptian cases with type 1 diabetes mellitus.
Settin A; Ismail A; El-Magd MA; El-Baz R; Kazamel A
Autoimmunity; 2009 Jan; 42(1):50-5. PubMed ID: 19127455
[TBL] [Abstract][Full Text] [Related]
12. TNF-alpha -308G>A polymorphism modulates cytokine serum concentrations and macrovascular complications in diabetic patients on aspirin.
Krayenbuehl PA; Wiesli P; Schmid M; Schmid C; Ehses JA; Hersberger M; Vetter W; Schulthess G
Exp Clin Endocrinol Diabetes; 2007 May; 115(5):322-6. PubMed ID: 17516296
[TBL] [Abstract][Full Text] [Related]
13. Increased circulating big endothelin-1, endothelin-1 and atrial natriuretic peptide in infants and children with heart failure secondary to congenital heart disease.
Yeh JL; Hsu JH; Dai ZK; Liou SF; Chen IJ; Wu JR
Int J Cardiol; 2005 Sep; 104(1):15-20. PubMed ID: 16055212
[TBL] [Abstract][Full Text] [Related]
14. Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome).
Gastmann A; Sigusch HH; Henke A; Reinhardt D; Surber R; Gastmann O; Figulla HR
Am J Cardiol; 2004 May; 93(10):1260-4. PubMed ID: 15135700
[TBL] [Abstract][Full Text] [Related]
15. Association of TNF-alpha -308 polymorphism with the outcome of hepatitis B virus infection in Turkey.
Basturk B; Karasu Z; Kilic M; Ulukaya S; Boyacioglu S; Oral B
Infect Genet Evol; 2008 Jan; 8(1):20-5. PubMed ID: 17974504
[TBL] [Abstract][Full Text] [Related]
16. Impact of endothelin-1 Lys198Asn polymorphism on coronary artery disease and endorgan damage in hypertensives.
Popov AF; Schulz EG; Hinz J; Schmitto JD; Seipelt R; Koziolek MJ; Rosenberger A; Schoendube FA; Müller GA
Coron Artery Dis; 2008 Nov; 19(7):429-34. PubMed ID: 18923236
[TBL] [Abstract][Full Text] [Related]
17. Role of non-HLA genetic variants in end-stage renal disease.
Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S
Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
[TBL] [Abstract][Full Text] [Related]
18. Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction.
Norata GD; Ongari M; Garlaschelli K; Tibolla G; Grigore L; Raselli S; Vettoretti S; Baragetti I; Noto D; Cefalù AB; Buccianti G; Averna M; Catapano AL
J Intern Med; 2007 Jul; 262(1):104-12. PubMed ID: 17598818
[TBL] [Abstract][Full Text] [Related]
19. Association of the -250G/A promoter polymorphism of the hepatic lipase gene with the risk of peripheral arterial disease in type 2 diabetic patients.
Valdivielso P; Ariza MJ; de la Vega-Román C; González-Alegre T; Rioja J; Ulzurrun E; González-Santos P
J Diabetes Complications; 2008; 22(4):273-7. PubMed ID: 18413186
[TBL] [Abstract][Full Text] [Related]
20. Additive effects of the chemokine receptor 2, vitamin D receptor, interleukin-6 polymorphisms and cardiovascular risk factors on the prevalence of myocardial infarction in patients below 65 years.
Ortlepp JR; Krantz C; Kimmel M; von Korff A; Vesper K; Schmitz F; Mevissen V; Janssens U; Franke A; Hanrath P; Zerres K; Hoffmann R
Int J Cardiol; 2005 Oct; 105(1):90-5. PubMed ID: 16207551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
